MISSISSAUGA, Ont. (CP) - Cipher Pharmaceuticals Inc. (TSX:DND), a Toronto-area drug developer, narrowed its losses in the fourth quarter on a reduction in research costs.
From: www.canadianbusiness.com
Cipher reports lower Q4 loss as research costs fall, names new CFO
Posted by Ruslan Abuzant at 10:36 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment